Drug Trial Radar · NCT00731679
Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
Last checked: Nov 20, 2026Latest source record: Nov 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
623
Actual
Start
Jul 2008
Primary completion
Aug 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 11, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy of a 14-day course of rifaximin given 3 times a day vs. placebo in providing adequate relief of IBS symptoms.
Conditions
- Non-Constipation Irritable Bowel Syndrome
Interventions
RifaximinDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who Had Adequate Relief of Global IBS Symptoms for at Least 2 of the 4 Weeks During the Primary Evaluation Period (ie, Weeks 3 Through 6).Time frame: 4 weeks
Locations
96 sites in 2 countries. Site status is shown where the registry gives one.
Site not named
Hueytown, Alabama
Site not named
Phoenix, Arizona
Site not named
Sierra Vista, Arizona
Site not named
Tucson, Arizona
Site not named
Little Rock, Arkansas
Site not named
Little Rock, Arkansas
Site not named
Sherwood, Arkansas
Site not named
Anaheim, California
Site not named
Lancaster, California
Site not named
Los Angeles, California
Site not named
Murrieta, California
Site not named
San Diego, California
Site not named
Lakewood, Colorado
Site not named
Bridgeport, Connecticut
Site not named
Torrington, Connecticut
Site not named
Altamonte Springs, Florida
Site not named
Boynton Beach, Florida
Site not named
Gainesville, Florida
Site not named
Hollywood, Florida
Site not named
Jupiter, Florida
Site not named
Lauderdale Lakes, Florida
Site not named
Maitland, Florida
Site not named
Naples, Florida
Site not named
New Port Richey, Florida
Site not named
Orlando, Florida
Site not named
West Palm Beach, Florida
Site not named
Winter Garden, Florida
Site not named
Winter Park, Florida
Site not named
Topeka, Kansas
Site not named
Shreveport, Louisiana
Site not named
Baltimore, Maryland
Site not named
Hagerstown, Maryland
Site not named
Silver Spring, Maryland
Site not named
Boston, Massachusetts
Site not named
Detroit, Michigan
Site not named
Kalamazoo, Michigan
Site not named
Paw Paw, Michigan
Site not named
Jackson, Mississippi
Site not named
St Louis, Missouri
Site not named
Lebanon, New Hampshire
Showing 40 of 96 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.